Drugmakers have been spending hundreds of millions of dollars for access to patient information because of the data’s potential to help unlock disease insights and discover new drugs.
They are striking deals to sequence patients’ genetic code, including with hospital systems like Geisinger in Pennsylvania, Mount Sinai Health System in New York and Mayo Clinic in...
Drug maker usage is negligible when compared to the nefarious use that Insurance companies may use against individuals. Insurance is legalized gambling and DNA data further gives “The House” an enormous advantage to the wager. Individuals the BIG losers.
If a drug company profits from the DNA, but in doing so, creates a drug that has a benefit to the group who’s DNA was utilized, haven’t we all won?